Literature DB >> 23313063

Role of creatine as biomarker of mitochondrial diseases.

Sonia Pajares1, Angela Arias, Judit García-Villoria, Paz Briones, Antonia Ribes.   

Abstract

Recent investigations have suggested creatine (Cr) as an additional biomarker of mitochondrial diseases. With the aim of corroborating previous findings, we have studied plasma Cr in a cohort of 33 patients with different mitochondrial diseases. Cr was clearly increased in 9 out of 33 patients. Therefore, positive patients represent only 28% of the total number, suggesting that Cr is not a sensitive biomarker of mitochondrial diseases although it does present an acceptable specificity (83%). High plasma Cr, together with other biomarkers, might be useful to reinforce the diagnosis of mitochondrial diseases.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23313063     DOI： 10.1016/j.ymgme.2012.11.283

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN： 1096-7192            Impact factor:   4.797


  9 in total

Review 1.  Precision medicine for disease modification in Parkinson disease.

Authors:  Alberto J Espay; Patrik Brundin; Anthony E Lang
Journal:  Nat Rev Neurol       Date:  2017-01-20       Impact factor: 42.937

2.  Early detection of elevated lactate levels in a mitochondrial disease model using chemical exchange saturation transfer (CEST) and magnetic resonance spectroscopy (MRS) at 7T-MRI.

Authors:  Shigeyoshi Saito; Yusuke Takahashi; Akiko Ohki; Yasunori Shintani; Takahiro Higuchi
Journal:  Radiol Phys Technol       Date:  2018-11-22

3.  Mitochondrial Respiratory Disorders: A Perspective on their Metabolite Biomarkers and Implications for Clinical Diagnosis and Therapeutic Intervention.

Authors:  Martine Uittenbogaard; Anne Chiaramello
Journal:  Biomark J       Date:  2015-10-12

4.  Laboratory diagnosis of creatine deficiency syndromes: a technical standard and guideline of the American College of Medical Genetics and Genomics.

Authors:  J Daniel Sharer; Olaf Bodamer; Nicola Longo; Silvia Tortorelli; Mirjam M C Wamelink; Sarah Young
Journal:  Genet Med       Date:  2017-01-05       Impact factor: 8.822

5.  Human Suction Blister Fluid Composition Determined Using High-Resolution Metabolomics.

Authors:  Megan M Niedzwiecki; Pradnya Samant; Douglas I Walker; ViLinh Tran; Dean P Jones; Mark R Prausnitz; Gary W Miller
Journal:  Anal Chem       Date:  2018-02-27       Impact factor: 6.986

6.  Plasma creatine and incident type 2 diabetes in a general population-based cohort: The PREVEND study.

Authors:  Adrian Post; Dion Groothof; Joëlle C Schutten; Jose L Flores-Guerrero; J Casper Swarte; Rianne M Douwes; Ido P Kema; Rudolf A de Boer; Erwin Garcia; Marge A Connelly; Theo Wallimann; Robin P F Dullaart; Casper F M Franssen; Stephan J L Bakker
Journal:  Clin Endocrinol (Oxf)       Date:  2021-01-10       Impact factor: 3.478

7.  Circulating FGF21 and GDF15 as Biomarkers for Screening, Diagnosis, and Severity Assessment of Primary Mitochondrial Disorders in Children.

Authors:  Yi Li; Shengrui Li; Yinfeng Qiu; Maobin Zhou; Min Chen; Yue Hu; Siqi Hong; Li Jiang; Yi Guo
Journal:  Front Pediatr       Date:  2022-04-14       Impact factor: 3.418

8.  A Metabolic Signature of Mitochondrial Dysfunction Revealed through a Monogenic Form of Leigh Syndrome

Authors:  Julie Thompson Legault; Laura Strittmatter; Jessica Tardif; Rohit Sharma; Vanessa Tremblay-Vaillancourt; Chantale Aubut; Gabrielle Boucher; Clary B Clish; Denis Cyr; Caroline Daneault; Paula J Waters; Luc Vachon; Charles Morin; Catherine Laprise; John D Rioux; Vamsi K Mootha; Christine Des Rosiers
Journal:  Cell Rep       Date:  2015-10-22       Impact factor: 9.423

9.  Expanding and validating the biomarkers for mitochondrial diseases.

Authors:  Alessandra Maresca; Valentina Del Dotto; Martina Romagnoli; Chiara La Morgia; Lidia Di Vito; Mariantonietta Capristo; Maria Lucia Valentino; Valerio Carelli
Journal:  J Mol Med (Berl)       Date:  2020-08-26       Impact factor: 4.599
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.